Boulud Pierre 4

What Happened
Pierre Boulud, a director of STERIS plc (STE), was granted 367 Career Restricted Stock Units (RSUs) on 2026-06-02. The Form 4 reports these as a derivative acquisition (code A) at $0.00 per unit (no cash paid). The award is not an open-market purchase or sale — it’s a compensation/award grant.

Key Details

• Transaction date: 2026-06-02; Form 4 filed: 2026-06-04 (timely).
• Transaction type/code: Award/Grant (A); derivative reported.
• Amount: 367 Career Restricted Stock Units; reported acquisition price $0.00.
• Shares owned after transaction: Not disclosed in this filing.
• Footnotes:
  • F1: Each Career RSU represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
  • F2: These Career RSUs are fully vested immediately and will be settled in STERIS ordinary shares six months after the director leaves the Board.

Context
This is an equity award to a director, not a market buy or sell, so it shouldn’t be read as a direct trading signal. Because the RSUs are fully vested but convertible to shares only six months after his Board service ends, the award creates a future entitlement rather than immediate share ownership in the market.